• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜母细胞瘤动脉内化疗期间的辐射毒性作用:我们应该关注吗?

Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned?

作者信息

Vijayakrishnan Rajakrishnan, Shields Carol L, Ramasubramanian Aparna, Emrich Jacqueline, Rosenwasser Robert, Shields Jerry A

机构信息

Internal Medicine Department, Saint Vincent Hospital, Worcester, Massachusetts, USA.

出版信息

Arch Ophthalmol. 2010 Nov;128(11):1427-31. doi: 10.1001/archophthalmol.2010.258.

DOI:10.1001/archophthalmol.2010.258
PMID:21060044
Abstract

OBJECTIVE

To evaluate irradiation toxic effects from fluoroscopy during intra-arterial chemotherapy for retinoblastoma.

DESIGN

Prospective trial.

PARTICIPANTS

Eight patients treated with intra-arterial chemotherapy.

MAIN OUTCOME MEASURES

Irradiation toxic effects in vital organs.

RESULTS

The mean patient age was 29 months (range, 10-74 months) and 63% were male. The mean irradiation dose to the skin of the affected eye was 0.19173 Gy, to the contralateral eye was 0.03533 Gy, to the chest wall was 0.00296 Gy, and to the abdominal wall was 0.00104 Gy. The estimated irradiation dose to the lens in the treatment eye was 0.16 Gy, which, in accumulated doses, could be cataractogenic. The estimated irradiation dose from a single fluoroscopy session to other organs, including the brain (0.05560 Gy), thyroid (0.00192 Gy), bone marrow (0.00059 Gy), and gonads (0.00015 Gy), was far lower than the minimal toxic level.

CONCLUSIONS

Careful use of fluoroscopy during intra-arterial chemotherapy with limited irradiation exposure is advised. Accumulated irradiation toxic effects following multiple sessions of intra-arterial chemotherapy could be cataractogenic and possibly carcinogenic, especially in irradiation-sensitive patients with retinoblastoma.

摘要

目的

评估视网膜母细胞瘤动脉内化疗期间透视检查的辐射毒性作用。

设计

前瞻性试验。

参与者

8例接受动脉内化疗的患者。

主要观察指标

重要器官的辐射毒性作用。

结果

患者平均年龄为29个月(范围10 - 74个月),63%为男性。患眼皮肤的平均辐射剂量为0.19173 Gy,对侧眼为0.03533 Gy,胸壁为0.00296 Gy,腹壁为0.00104 Gy。治疗眼晶状体的估计辐射剂量为0.16 Gy,累积剂量可能致白内障。单次透视检查对其他器官(包括脑(0.05560 Gy)、甲状腺(0.00192 Gy)、骨髓(0.00059 Gy)和性腺(0.00015 Gy))的估计辐射剂量远低于最小毒性水平。

结论

建议在动脉内化疗期间谨慎使用透视检查,限制辐射暴露。多次动脉内化疗后的累积辐射毒性作用可能致白内障,甚至可能致癌,尤其是对辐射敏感的视网膜母细胞瘤患者。

相似文献

1
Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned?视网膜母细胞瘤动脉内化疗期间的辐射毒性作用:我们应该关注吗?
Arch Ophthalmol. 2010 Nov;128(11):1427-31. doi: 10.1001/archophthalmol.2010.258.
2
Radiation exposure during intra-arterial chemotherapy for retinoblastoma.视网膜母细胞瘤动脉内化疗期间的辐射暴露。
Arch Ophthalmol. 2012 Mar;130(3):403-4; author reply 404-5. doi: 10.1001/archopthalmol.2011.2717.
3
Radiation dose reduction in intra-arterial chemotherapy infusion for intraocular retinoblastoma.眼内视网膜母细胞瘤动脉内化疗输注中的辐射剂量降低
J Neurointerv Surg. 2014 Dec;6(10):785-9. doi: 10.1136/neurintsurg-2013-010905. Epub 2014 Jan 2.
4
Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.动脉内化疗治疗视网膜母细胞瘤:四年经验
Arch Ophthalmol. 2011 Jun;129(6):732-7. doi: 10.1001/archophthalmol.2011.5. Epub 2011 Feb 14.
5
Technical and anatomical factors affecting intra-arterial chemotherapy fluoroscopy time and radiation dose for intraocular retinoblastoma.影响眼内视网膜母细胞瘤经动脉内化疗透视时间和辐射剂量的技术和解剖因素。
J Neurointerv Surg. 2019 Dec;11(12):1273-1276. doi: 10.1136/neurintsurg-2019-014910. Epub 2019 Jun 13.
6
Cataract formation: a possible complication of intra-arterial chemotherapy for retinoblastoma.白内障形成:视网膜母细胞瘤动脉内化疗的一种可能并发症。
Eur J Ophthalmol. 2014 May-Jun;24(3):449-53. doi: 10.5301/ejo.5000393. Epub 2013 Nov 7.
7
Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).超选择性眼动脉化疗作为视网膜母细胞瘤(化疗手术)的主要治疗方法。
Ophthalmology. 2010 Aug;117(8):1623-9. doi: 10.1016/j.ophtha.2009.12.030. Epub 2010 Apr 9.
8
Intra-arterial chemotherapy for retinoblastoma: the dosimetric impact.眼内动脉化疗治疗视网膜母细胞瘤:剂量学影响。
Neuroradiology. 2019 Sep;61(9):1083-1091. doi: 10.1007/s00234-019-02260-7. Epub 2019 Jul 22.
9
Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey.眼内动脉化疗治疗视网膜母细胞瘤:漫漫征程的起点。
Clin Exp Ophthalmol. 2010 Aug;38(6):638-43. doi: 10.1111/j.1442-9071.2010.02297.x. Epub 2010 Mar 25.
10
Intra-arterial and oral digoxin therapy for retinoblastoma.动脉内和口服地高辛治疗视网膜母细胞瘤。
Ophthalmic Genet. 2011 Sep;32(3):147-50. doi: 10.3109/13816810.2010.544530. Epub 2011 Mar 29.

引用本文的文献

1
Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success.评估接受超选择性动脉内化疗治疗视网膜母细胞瘤的儿童的辐射暴露:根据年龄、性别和介入成功情况评估局部诊断参考水平。
Neuroradiology. 2021 Mar;63(3):391-398. doi: 10.1007/s00234-020-02540-7. Epub 2020 Aug 29.
2
Eye lens radiation exposure in paediatric interventional treatment of retinoblastoma.儿童视网膜母细胞瘤介入治疗的晶状体辐射暴露。
Sci Rep. 2019 Dec 27;9(1):20113. doi: 10.1038/s41598-019-56623-4.
3
Intra-arterial chemotherapy for retinoblastoma: the dosimetric impact.
眼内动脉化疗治疗视网膜母细胞瘤:剂量学影响。
Neuroradiology. 2019 Sep;61(9):1083-1091. doi: 10.1007/s00234-019-02260-7. Epub 2019 Jul 22.
4
The technique of superselective ophthalmic artery chemotherapy for retinoblastoma: The Garrahan Hospital experience.视网膜母细胞瘤超选择性眼动脉化疗技术:加拉汉医院的经验
Interv Neuroradiol. 2018 Feb;24(1):93-99. doi: 10.1177/1591019917738962. Epub 2017 Nov 9.
5
Outcome of retinoblastoma following limited sessions of intra-arterial chemotherapy in iran.伊朗有限疗程动脉内化疗后视网膜母细胞瘤的治疗结果
Iran J Radiol. 2014 Aug;11(3):e16958. doi: 10.5812/iranjradiol.16958. Epub 2014 Aug 1.
6
Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution.超选择性动脉内美法仑治疗新诊断及难治性视网膜母细胞瘤:单机构研究结果
Clin Ophthalmol. 2013;7:981-9. doi: 10.2147/OPTH.S43398. Epub 2013 May 27.
7
A clinical update and radiologic review of pediatric orbital and ocular tumors.儿童眼眶和眼内肿瘤的临床更新和放射学回顾。
J Oncol. 2013;2013:975908. doi: 10.1155/2013/975908. Epub 2013 Mar 12.
8
Current therapy and recent advances in the management of retinoblastoma.视网膜母细胞瘤治疗现状与最新进展
Indian J Med Paediatr Oncol. 2012 Apr;33(2):80-8. doi: 10.4103/0971-5851.99731.
9
Retinoblastoma: Recent trends A mini review based on published literature.视网膜母细胞瘤:近期趋势 基于已发表文献的小型综述
Oman J Ophthalmol. 2011 Sep;4(3):108-15. doi: 10.4103/0974-620X.91265.
10
Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma.经后交通动脉逆行进入眼动脉行视网膜母细胞瘤的动脉内化疗。
Neuroradiology. 2012 Aug;54(8):845-8. doi: 10.1007/s00234-011-0978-4. Epub 2011 Nov 18.